FDA Approves Ocular Implant for Vision-Threatening MacTel

MedPage Today) — The FDA approved revakinagene taroretcel (Encelto) as the first treatment for adults with idiopathic macular telangiectasia (MacTel) type 2, Neurotech Pharmaceuticals announced on Thursday. A rare, progressive neurodegenerative…

About Author

Leigha Kazmierczak

See author's posts

FDA Approves Ocular Implant for Vision-Threatening MacTel

About Author

Leigha Kazmierczak

Drug pollution in water is making salmon take more risks

Acute and chronic stress have markedly different impacts on neural repair in a depression-linked brain region

RFK Jr’s autism ‘epidemic’ study raises anti-vaxx fears

Drug pollution in water is making salmon take more risks

Acute and chronic stress have markedly different impacts on neural repair in a depression-linked brain region

Pandemic agreement: key points under discussion

RFK Jr’s autism ‘epidemic’ study raises anti-vaxx fears

US measles cases surpass 700 with outbreaks in six states. Here’s what to know

FDA Approves BV+R2 Combo for R/R LBCL

Transplant Recipients Face High Risk for Actinic Keratosis

Small Town Offers Big Perks to Attract a Physician

How Bad Will It Get? Flu Rates Are Still Rising

Weight Loss Drug Curbs Alcohol Cravings, Consumption

Drug pollution in water is making salmon take more risks

Acute and chronic stress have markedly different impacts on neural repair in a depression-linked brain region

Pandemic agreement: key points under discussion

RFK Jr’s autism ‘epidemic’ study raises anti-vaxx fears

US measles cases surpass 700 with outbreaks in six states. Here’s what to know

About PhaMed

Recent News

About Author

More Stories

You may have missed

About PhaMed

Recent News

Categories